Antimicrobial Susceptibility Testing Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Antimicrobial Susceptibility Testing Market By Product Type (Manual Antimicrobial Susceptibility Testing Product(Susceptibility Testing Disks, MIC Strips, and Susceptibility Testing Plates), Automated Laboratory Instruments, Culture and Growth Media, and Consumables)), Type(Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, and Other Susceptibility Testing Types (slow-growing pathogens), Method (Etest Method, Disk Diffusion, Automated Susceptibility Testing Instruments, Agar Dilution, Genotyping Methods), Application Type (Clinical Diagnostics, Drug Discovery and Development, Epidemiology, and Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations (CROs)), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Antimicrobial Susceptibility Testing Market is expected to be valued at USD 3,645.3 million in 2022, growing at a 6.2% CAGR from 2022 to 2028. Antimicrobial susceptibility testing (AST) is a laboratory procedure to identify an accurate antimicrobial regimen against microbes. AST of the connective agent(s) is essential for judiciously selecting appropriate antimicrobial therapy. The market is primarily driven by the increasing number of pathogenic bacteria gaining antibiotic resistance and new forms of resistance are steadily emerging, which enable clinicians to execute antimicrobial susceptibility testing (AST) with urgency. A rapid multiplexed AST platform delivers minimum inhibitory concentrations (MICs) within hours at a feasible cost, which empowers rapid determination of effective targeted bacteriophage therapy, ensuing in short hospital stays, and fewer laboratory tests, decreasing morbidity and mortality along with their healthcare expenses. These advancements in the health care sector further enhance the Antimicrobial Susceptibility Testing Market growth. Furthermore, the increasing number of new launches of products based on various technologies are expected to push the market growth. For instance, the CE-marked Alfred 60 AST system of Alifax S.r.l. Italy, a company specializing in the development, production, and distribution of automated clinical diagnostic instruments, practices sensitive laser-light scattering technology to detect bacterial growth in a liquid culture broth and provides antimicrobial susceptibility results directly from positive blood culture bottles within 4–6 hours. Furthermore, in 2018, Beckman Coulter Inc., a subsidiary of Danaher, announced the commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial detection and antibiotic susceptibility testing for microbiology research laboratories.

Recent Market Developments:

In February 2020, Bio-Rad Laboratories, Inc., a global company engaged in developing, manufacturing, and marketing an extensive range of innovative products for the life science research and clinical diagnostic markets, developed Exact Diagnostics.

Antimicrobial Susceptibility Testing Market

MARKET SUMMARY
-
6.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.2%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Antimicrobial Susceptibility Testing Market

  • The report on global antimicrobial susceptibility testing market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, type, method, application, end user, and geography.
  • The global antimicrobial susceptibility testing market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson, and Company,
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Beckman Coulter)
  • Hoffmann-La Roche AG
Antimicrobial Susceptibility Testing Market Dynamics

The market for antimicrobial susceptibility is growing due to the high incidence of infectious diseases, increasing government programs and investment in antimicrobial susceptibility testing programs, technological advancements for developing new AST methods, and the rise of multidrug resistance in microorganisms. Increasing R&D activities to develop speedy antimicrobial susceptibility testing are anticipated to create attractive growth opportunities for players operating in the antimicrobial susceptibility testing market. The expansion of the Antimicrobial Susceptibility Testing Market is constrained by the high cost of automated and other antimicrobial susceptibility testing systems and stringent government regulations.


North-America Got Significant Share

Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing Market in North America is likely to hold a significant revenue share in 2021, and in the following years, it is predicted to increase rapidly, owing to the advanced healthcare infrastructure and rapid technological advancement in the discoveries of new drugs. Furthermore, the frequent launches of varieties of products in this region favor dominating the Antimicrobial Susceptibility Testing Market during the forecasted period. The Asia Pacific is also witnessed to have a considerable growth rate in upcoming years due to joint efforts by the government, health authorities, and medical professionals to fight antimicrobial resistance, high demand for antibiotics, and rising issues of Methicillin-resistant Staphylococcus aureus and rising prevalence of sepsis and HIV/AIDS.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The antimicrobial susceptibility testing market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Antimicrobial Susceptibility Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

Antimicrobial susceptibility testing (AST) is a laboratory practice performed by medical technologists (clinical laboratory scientists) to identify a particular antimicrobial regimen is specifically effective for individual patients. On a larger scale, it aids in the assessment of treatment services provided by hospitals, clinics, and national programs for the control and prevention of infectious diseases.

Key players’ profiles in the antimicrobial susceptibility testing market report are Accelerate Diagnostics, Inc., Becton, Dickinson, and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Bruker Danaher Corporation (Beckman Coulter), and F. Hoffmann-La Roche AG.

A rise in the incidence of infectious diseases and the emergence of multidrug resistance across globe.


Report

Table Of Content

1. Executive Summary
2. Global Antimicrobial Susceptibility Testing Market Introduction
2.1. Global Antimicrobial Susceptibility Testing Market – Taxonomy
2.2. Global Antimicrobial Susceptibility Testing Market –Definitions
2.2.1. By Product
2.2.2. By Type
2.2.3. By Method
2.2.4. By Application
2.2.5. By End User
2.2.6. By Region
3. Global Antimicrobial Susceptibility Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Antimicrobial Susceptibility Testing Market Dynamic Factors – Impact Analysis
3.6. Global Antimicrobial Susceptibility Testing Market – Competition Landscape
4. Global Antimicrobial Susceptibility Testing Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Antimicrobial Susceptibility Testing Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Manual Antimicrobial Susceptibility Testing Products
5.1.1. Susceptibility Testing Disks
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. MIC Strips
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Susceptibility Testing Plates
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.2. Automated Laboratory Instruments
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Culture and Growth Media
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Consumables
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Antimicrobial Susceptibility Testing Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Antibacterial Susceptibility Testing
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Antifungal Susceptibility Testing
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Antiparasitic Susceptibility Testing
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Other Susceptibility Testing Types (slow-growing pathogens)
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Antimicrobial Susceptibility Testing Market, By Method, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.  Etest Method
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Disk Diffusion
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Automated Susceptibility Testing Instruments
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Agar Dilution
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Genotyping Methods
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Antimicrobial Susceptibility Testing Market Forecast, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Clinical Diagnostics
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Drug Discovery and Development
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Epidemiology
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Antimicrobial Susceptibility Testing Market Forecast, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. Hospitals and Diagnostic Centers
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Pharmaceutical and Biotechnology Companies
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Research & Academic Institutes
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Clinical Research Organizations (CROs)
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Antimicrobial Susceptibility Testing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Antimicrobial Susceptibility Testing Market – Opportunity Analysis Index, By Product, By Type, By Method, By Application, By End User, and Region, 2022-2028
11. North America Antimicrobial Susceptibility Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Manual Antimicrobial Susceptibility Testing Products
11.1.1.1. Susceptibility Testing Disks
11.1.1.2. MIC Strips
11.1.1.3. Susceptibility Testing Plates
11.1.2. Automated Laboratory Instruments
11.1.3. Culture and Growth Media
11.1.4. Consumables
11.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Antibacterial Susceptibility Testing
11.2.2. Antifungal Susceptibility Testing
11.2.3. Antiparasitic Susceptibility Testing
11.2.4. Other Susceptibility Testing Types (slow-growing pathogens)
11.3. Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Etest Method
11.3.2. Disk Diffusion
11.3.3. Automated Susceptibility Testing Instruments
11.3.4. Agar Dilution
11.3.5. Genotyping Methods
11.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Clinical Diagnostics
11.4.2. Drug Discovery and Development
11.4.3. Epidemiology
11.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
11.5. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Hospitals and Diagnostic Centers
11.5.2. Pharmaceutical and Biotechnology Companies
11.5.3. Research & Academic Institutes
11.5.4. Clinical Research Organizations (CROs)
11.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Antimicrobial Susceptibility Testing Market – Opportunity Analysis Index, By Product, Type, Method, Application, End User, and Country, 2022-2028
11.8. North America Antimicrobial Susceptibility Testing Market Dynamics – Trends
12. Europe Antimicrobial Susceptibility Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Manual Antimicrobial Susceptibility Testing Products
12.1.1.1. Susceptibility Testing Disks
12.1.1.2. MIC Strips
12.1.1.3. Susceptibility Testing Plates
12.1.2. Automated Laboratory Instruments
12.1.3. Culture and Growth Media
12.1.4. Consumables
12.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Antibacterial Susceptibility Testing
12.2.2. Antifungal Susceptibility Testing
12.2.3. Antiparasitic Susceptibility Testing
12.2.4. Other Susceptibility Testing Types (slow-growing pathogens)
12.3. Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Etest Method
12.3.2. Disk Diffusion
12.3.3. Automated Susceptibility Testing Instruments
12.3.4. Agar Dilution
12.3.5. Genotyping Methods
12.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Clinical Diagnostics
12.4.2. Drug Discovery and Development
12.4.3. Epidemiology
12.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
12.5. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Hospitals and Diagnostic Centers
12.5.2. Pharmaceutical and Biotechnology Companies
12.5.3. Research & Academic Institutes
12.5.4. Clinical Research Organizations (CROs)
12.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Rest of Europe
12.7. Europe Antimicrobial Susceptibility Testing Market – Opportunity Analysis Index, By Product, Type, Method, Application, End User, and Country, 2022-2028
12.8. Europe Antimicrobial Susceptibility Testing Market Dynamics – Trends
13. Asia-Pacific Antimicrobial Susceptibility Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Manual Antimicrobial Susceptibility Testing Products
13.1.1.1. Susceptibility Testing Disks
13.1.1.2. MIC Strips
13.1.1.3. Susceptibility Testing Plates
13.1.2. Automated Laboratory Instruments
13.1.3. Culture and Growth Media
13.1.4. Consumables
13.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Antibacterial Susceptibility Testing
13.2.2. Antifungal Susceptibility Testing
13.2.3. Antiparasitic Susceptibility Testing
13.2.4. Other Susceptibility Testing Types (slow-growing pathogens)
13.3. Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Etest Method
13.3.2. Disk Diffusion
13.3.3. Automated Susceptibility Testing Instruments
13.3.4. Agar Dilution
13.3.5. Genotyping Methods
13.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Clinical Diagnostics
13.4.2. Drug Discovery and Development
13.4.3. Epidemiology
13.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
13.5. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Hospitals and Diagnostic Centers
13.5.2. Pharmaceutical and Biotechnology Companies
13.5.3. Research & Academic Institutes
13.5.4. Clinical Research Organizations (CROs)
13.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Antimicrobial Susceptibility Testing Market – Opportunity Analysis Index, By Product, Type, Method, Application, End User, and Country, 2022-2028
13.8. Asia-Pacific Antimicrobial Susceptibility Testing Market Dynamics – Trends
14. Latin America Antimicrobial Susceptibility Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Manual Antimicrobial Susceptibility Testing Products
14.1.1.1. Susceptibility Testing Disks
14.1.1.2. MIC Strips
14.1.1.3. Susceptibility Testing Plates
14.1.2. Automated Laboratory Instruments
14.1.3. Culture and Growth Media
14.1.4. Consumables
14.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Antibacterial Susceptibility Testing
14.2.2. Antifungal Susceptibility Testing
14.2.3. Antiparasitic Susceptibility Testing
14.2.4. Other Susceptibility Testing Types (slow-growing pathogens)
14.3. Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Etest Method
14.3.2. Disk Diffusion
14.3.3. Automated Susceptibility Testing Instruments
14.3.4. Agar Dilution
14.3.5. Genotyping Methods
14.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Clinical Diagnostics
14.4.2. Drug Discovery and Development
14.4.3. Epidemiology
14.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
14.5. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Hospitals and Diagnostic Centers
14.5.2. Pharmaceutical and Biotechnology Companies
14.5.3. Research & Academic Institutes
14.5.4. Clinical Research Organizations (CROs)
14.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Antimicrobial Susceptibility Testing Market – Opportunity Analysis Index, By Product, Type, Method, Application, End User, and Country, 2022-2028
14.8. Latin America Antimicrobial Susceptibility Testing Market Dynamics – Trends
15. Middle East and Africa Antimicrobial Susceptibility Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
15.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Manual Antimicrobial Susceptibility Testing Products
15.1.1.1. Susceptibility Testing Disks
15.1.1.2. MIC Strips
15.1.1.3. Susceptibility Testing Plates
15.1.2. Automated Laboratory Instruments
15.1.3. Culture and Growth Media
15.1.4. Consumables
15.2. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Antibacterial Susceptibility Testing
15.2.2. Antifungal Susceptibility Testing
15.2.3. Antiparasitic Susceptibility Testing
15.2.4. Other Susceptibility Testing Types (slow-growing pathogens)
15.3. Method Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Etest Method
15.3.2. Disk Diffusion
15.3.3. Automated Susceptibility Testing Instruments
15.3.4. Agar Dilution
15.3.5. Genotyping Methods
15.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Clinical Diagnostics
15.4.2. Drug Discovery and Development
15.4.3. Epidemiology
15.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
15.5. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Hospitals and Diagnostic Centers
15.5.2. Pharmaceutical and Biotechnology Companies
15.5.3. Research & Academic Institutes
15.5.4. Clinical Research Organizations (CROs)
15.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. South Africa
15.6.3. Rest of MEA
15.7. MEA Antimicrobial Susceptibility Testing Market – Opportunity Analysis Index, By Product, Type, Method, Application, End User, and Country, 2022-2028
15.8. MEA Antimicrobial Susceptibility Testing Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Accelerate Diagnostics, Inc.
16.2.2. Becton, Dickinson and Company,
16.2.3. Biomerieux SA,
16.2.4. Bio-Rad Laboratories, Inc.,
16.2.5. Bruker,
16.2.6. Danaher Corporation (Beckman Coulter),
16.2.7. F. Hoffmann-La Roche AG,
16.2.8. HiMedia Laboratories,
16.2.9. Merck KGaA (MilliporeSigma),
16.2.10. Thermo Fisher Scientific
17. Research Methodology
18. Key Assumptions and Acronyms

Report

Company Profile

  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company,
  • Biomerieux SA,
  • Bio-Rad Laboratories, Inc.,
  • Bruker,
  • Danaher Corporation (Beckman Coulter),
  • Hoffmann-La Roche AG,
  • HiMedia Laboratories,
  • Merck KGaA (MilliporeSigma),
  • Thermo Fisher Scientific

Description

Antimicrobial Susceptibility Testing Market is expected to be valued at USD 3,645.3 million in 2022, growing at a 6.2% CAGR from 2022 to 2028. Antimicrobial susceptibility testing (AST) is a laboratory procedure to identify an accurate antimicrobial regimen against microbes. AST of the connective agent(s) is essential for judiciously selecting appropriate antimicrobial therapy. The market is primarily driven by the increasing number of pathogenic bacteria gaining antibiotic resistance and new forms of resistance are steadily emerging, which enable clinicians to execute antimicrobial susceptibility testing (AST) with urgency. A rapid multiplexed AST platform delivers minimum inhibitory concentrations (MICs) within hours at a feasible cost, which empowers rapid determination of effective targeted bacteriophage therapy, ensuing in short hospital stays, and fewer laboratory tests, decreasing morbidity and mortality along with their healthcare expenses. These advancements in the health care sector further enhance the Antimicrobial Susceptibility Testing Market growth. Furthermore, the increasing number of new launches of products based on various technologies are expected to push the market growth. For instance, the CE-marked Alfred 60 AST system of Alifax S.r.l. Italy, a company specializing in the development, production, and distribution of automated clinical diagnostic instruments, practices sensitive laser-light scattering technology to detect bacterial growth in a liquid culture broth and provides antimicrobial susceptibility results directly from positive blood culture bottles within 4–6 hours. Furthermore, in 2018, Beckman Coulter Inc., a subsidiary of Danaher, announced the commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial detection and antibiotic susceptibility testing for microbiology research laboratories.

Recent Market Developments:

In February 2020, Bio-Rad Laboratories, Inc., a global company engaged in developing, manufacturing, and marketing an extensive range of innovative products for the life science research and clinical diagnostic markets, developed Exact Diagnostics.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX